Search Results for:

Application Deadline: 23/08/2019
Ref: PhD-SO

The Targeted therapeutics and nanodevices group led by Dr. Silvia Muro at the Institute for Bioengineering of Catalonia (IBEC) is looking for PhD Student to develop their research thesis on a project focused on the identification, characterization, and application of “universal” monoclonal antibodies capable of recognizing specific cell-surface receptors in a variety of species, as primary tools to then develop targeted drug delivery applications (nanoparticles and antibody-drug conjugates) for the treatment of neurodegenerative diseases.

The candidate will apply for a fellowship “Ayudas para contratos predoctorales para la formación de doctores” associated to the “Severo Ochoa Mención de Excelencia” granted to IBEC by the “Ministerio de Ciencia, Innovación y Universidades”.

Application Deadline: 23/08/2019
Ref: PhD- RETOS

The Targeted therapeutics and nanodevices group led by Dr. Silvia Muro at the Institute for Bioengineering of Catalonia (IBEC) is looking for PhD Student to develop their research thesis on a project focused on the identification, characterization, and application of “universal” monoclonal antibodies capable of recognizing specific cell-surface receptors in a variety of species, as primary tools to then develop targeted drug delivery applications (nanoparticles and antibody-drug conjugates) for the treatment of neurodegenerative diseases.

The candidate will apply for an “Ayudas para contratos predoctorales para la formación de doctores” fellowship associated to the project “CROSSTARGET: Development of new translational cross-species tools for therapeutic targeting with organ and subcellular precision”, which has been recently funded by the Ministerio de Ciencia, Innovación y Universidades, under its RETOS program.

Application Deadline: 23/08/2019
Ref: PD-SM

The Targeted therapeutics and nanodevices group led by Dr. Silvia Muro at the Institute for Bioengineering of Catalonia (IBEC) is looking for Postdoctoral candidate to collaborate in a research project focused on the identification, characterization, and application of “universal” monoclonal antibodies capable of recognizing specific cell-surface receptors in a variety of species, as primary tools to then develop targeted drug delivery applications (nanoparticles and antibody-drug conjugates) for the treatment of neurodegenerative diseases.

The contract will be within the framework of the project “CROSSTARGET: Development of new translational cross-species tools for therapeutic targeting with organ and subcellular precision”, funded by the Ministerio de Ciencia, Innovación y Universidades under its RETOS program.

Application Deadline: 31/08/2019
Ref: LA-XT
The Integrative cell and tissue dyamics group at the Institute for Bioengineering of Catalonia (IBEC) is looking for Laboratory Assistant to participate to a multidisciplinary research in the field of cancer disease. The aim of this work will focus on understanding the mechanical interaction between tumor/stromal that drive tumor spreading. The candidate will conduct experiment using diverse approaches such as: Cell culture, micro-fabrication techniques, traction force microscopy, live fluorescent microscopy and image analysis.

Application Deadline: 05/09/2019
Ref: PH-BB

The Protein phase Transitions in Health and Disease group at the Institute for Bioengineering of Catalonia (IBEC) is looking for an Early Stage Researcher (PhD student) to develop his/her PhD thesis project on Deep Mutagenesis of Prion Domains. The project will develop starting from recent work from the lab aimed at understanding the mechanisms by which certain proteins become toxic in neurodegenerative diseases, such as https://www.biorxiv.org/content/10.1101/592121v1.

Application Deadline: 22/08/2019
Ref: PD-JAD

The Molecular and cellular neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Postdoctoral Researcher to develop a project on the development of in vitro and in vivo spreading model of different isoforms of Tau.

The contract will be within the framework of La Caixa Health Foundation Project, whose objective is to determine the differential spreading of different isoforms of Tau.